GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medartis Holding AG (XSWX:MED) » Definitions » Total Liabilities

Medartis Holding AG (XSWX:MED) Total Liabilities : CHF192.0 Mil (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Medartis Holding AG Total Liabilities?

Medartis Holding AG's Total Liabilities for the quarter that ended in Jun. 2024 was CHF192.0 Mil.

Medartis Holding AG's quarterly Total Liabilities increased from Jun. 2023 (CHF89.87 Mil) to Dec. 2023 (CHF94.58 Mil) and increased from Dec. 2023 (CHF94.58 Mil) to Jun. 2024 (CHF191.95 Mil).

Medartis Holding AG's annual Total Liabilities increased from Dec. 2021 (CHF74.19 Mil) to Dec. 2022 (CHF90.12 Mil) and increased from Dec. 2022 (CHF90.12 Mil) to Dec. 2023 (CHF94.58 Mil).


Medartis Holding AG Total Liabilities Historical Data

The historical data trend for Medartis Holding AG's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medartis Holding AG Total Liabilities Chart

Medartis Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 72.94 69.76 74.19 90.12 94.58

Medartis Holding AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90.68 90.12 89.87 94.58 191.95

Medartis Holding AG Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Medartis Holding AG's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=45.956+(20.627+17.589
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+10.403)
=94.6

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=349.534-254.959
=94.6

Medartis Holding AG's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=57.104+(113.742+9.684
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+11.42)
=192.0

Total Liabilities=Total Assets (Q: Jun. 2024 )-Total Equity (Q: Jun. 2024 )
=464.516-272.566
=192.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medartis Holding AG Total Liabilities Related Terms

Thank you for viewing the detailed overview of Medartis Holding AG's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Medartis Holding AG Business Description

Traded in Other Exchanges
Address
Hochbergerstrasse 60E, Basel, CHE, 4057
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from EMEA and also has a presence in APAC, USA, LATAM, and North America.